Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast add-on treatment for hospitalized COVID-19 pneumonia
2020-001747-21Phase 4Completed
- Sponsor
- ISPUP
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of montelukast in coronavirus pneumonia (2 arms), sponsored by ISPUP. Primary endpoint: Improvement of COVID-19 disease status on 8-point ordinal scale. Started May 2020; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on 2020-001747-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001747-21.